Literature DB >> 9183638

Establishment of eighteen clones of Ishikawa cells.

M Nishida1, K Kasahara, A Oki, T Satoh, Y Arai, T Kubo.   

Abstract

Ishikawa cells, which derive from a well differentiated human endometrial adenocarcinoma, were cloned using the limiting dilution method in an attempt to preserve well differentiated cells. Eighteen clones were obtained. According to their morphologic characteristics, there were six well differentiated, seven moderately differentiated, three poorly differentiated and two adenosquamous carcinoma clones. All of them were transplantable into node mice. Fifteen of the 17 clones were positive for estrogen receptors and all of the clones examined were positive for progesterone receptors. There were no significant differences in terms of population doubling time, plating efficiency or saturation density among these clones. On the basis of these results, we concluded that Ishikawa cells are not as homogeneous morphologically as we thought, since cells with varying degrees of differentiation have already mingled with the parent cell line. It is verified that the adenosquamous cell carcinoma of the endometrium can arise from one stem cell. It would be impossible to revive the cultured cells after having undergone their changes to the original conditions. Therefore, to preserve the characteristics of an established cell line, the cells should be frozen at a very early stage. It is also important to avoid frequent passages when special characters of the cells are necessary for a given investigation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9183638

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  12 in total

Review 1.  The Ishikawa cells from birth to the present.

Authors:  Masato Nishida
Journal:  Hum Cell       Date:  2002-09       Impact factor: 4.174

2.  Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth.

Authors:  M J Pineda; Z Lu; D Cao; J J Kim
Journal:  Horm Cancer       Date:  2015-05-15       Impact factor: 3.869

3.  Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.

Authors:  Nikki L Neubauer; Erin C Ward; Parin Patel; Zhenxiao Lu; Irene Lee; Leen J Blok; Payman Hanifi-Moghaddam; Julian Schink; J Julie Kim
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

4.  Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation.

Authors:  Shifeng Su; Amanda J Blackwelder; Gail Grossman; John T Minges; Lingwen Yuan; Steven L Young; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

5.  DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.

Authors:  Christopher Korch; Monique A Spillman; Twila A Jackson; Britta M Jacobsen; Susan K Murphy; Bruce A Lessey; V Craig Jordan; Andrew P Bradford
Journal:  Gynecol Oncol       Date:  2012-06-16       Impact factor: 5.482

6.  Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation.

Authors:  Suxia Bai; Gail Grossman; Lingwen Yuan; Bruce A Lessey; Frank S French; Steven L Young; Elizabeth M Wilson
Journal:  Mol Hum Reprod       Date:  2007-11-29       Impact factor: 4.025

7.  Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.

Authors:  Yongli Chu; Yanlin Wang; Guanghua Zhang; Haibin Chen; Sean C Dowdy; Yuning Xiong; Fengming Liu; Run Zhang; Jinping Li; Shi-Wen Jiang
Journal:  Cell Mol Life Sci       Date:  2014-02-15       Impact factor: 9.261

8.  In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer.

Authors:  Samir A Saidi; Cathrine M Holland; D Stephen Charnock-Jones; Stephen K Smith
Journal:  Mol Cancer       Date:  2006-03-28       Impact factor: 27.401

9.  Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells.

Authors:  Naoko Koyama; Yoshihiro Nishida; Terukazu Ishii; Toshie Yoshida; Yuichi Furukawa; Hisashi Narahara
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

10.  Genomic characterization of five commonly used endometrial cancer cell lines.

Authors:  Eric J Devor; Jesus Gonzalez-Bosquet; Kristina W Thiel; Kimberly K Leslie
Journal:  Int J Oncol       Date:  2020-10-21       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.